Table 1.
Characteristics of the study population
| Characteristic | Overall (N=558) |
|---|---|
| Age (yr) | 11 (7, 14) |
| Male | 346 (62) |
| Race | |
| Caucasian | 371 (66) |
| African American | 127 (23) |
| Other | 33 (6) |
| Multiracial (non–African American) | 27 (5) |
| Hispanic ethnicity | 78 (14) |
| Glomerular CKD | 120 (22) |
| eGFR (ml/min per 1.73 m2) | 44 (33, 57) |
| Duration of CKD (yr) | 6 (3, 10) |
| Household annual income<$36,000 | 235 (42) |
| Total no. of unique medication groupsa | 3 (2, 5) |
| Total no. of CKD-specific medication groupsb | 2 (1, 4) |
Data are presented as the median (interquartile range) or n (%).
a
Unique medication groups includes those with <5% prevalence grouped separately (not grouped together as “other”).
b
CKD-specific medication groups excludes the non-CKD–related medications category and the “other” medication groupings.